Loading...
ROCO
4153
Market cap56mUSD
Jul 09, Last price  
30.90TWD
1D
-0.32%
1Q
-5.07%
Jan 2017
-27.38%
IPO
34.41%
Name

DIVA Laboratories Ltd

Chart & Performance

D1W1MN
ROCO:4153 chart
P/E
20.02
P/S
2.09
EPS
1.54
Div Yield, %
6.47%
Shrs. gr., 5y
-2.45%
Rev. gr., 5y
3.35%
Revenues
869m
+0.76%
716,170,000736,925,000712,232,000949,204,000893,844,000862,323,000868,840,000
Net income
91m
-3.33%
56,044,00017,418,00021,855,00049,661,00073,617,00093,661,00090,540,000
CFO
21m
-83.13%
52,663,000-16,644,000-11,390,00073,187,000252,913,000123,138,00020,769,000
Dividend
Jun 13, 20252 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DIVA Laboratories, Ltd. specializes in the global provision of advanced display technologies. Its comprehensive product lineup caters to critical environments, including specialized endo/surgical displays designed to render both static and dynamic imagery with precision for hybrid and integrated operating theaters, as well as crucial control room applications. Furthermore, DIVA offers a range of color and monochrome monitors tailored for high-accuracy radiology and broader medical imaging purposes. Beyond healthcare, the company develops interactive touch displays and human-machine interface (HMI) solutions, alongside robust medical and industrial enclosures. DIVA also serves original design manufacturers (ODMs) and original equipment manufacturers (OEMs) with custom display units, in addition to a broader portfolio of video solutions. Established in 1995, DIVA Laboratories, Ltd. maintains its corporate headquarters in New Taipei City, Taiwan.
IPO date
Oct 11, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT